Washington Trust Bank’s Teva Pharmaceuticals TEVA Stock Holding History

Washington Trust Bank’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-234	Closed	-$4K	–	506
2019 Q1	$4K	Hold	234	–	–	﹤0.01%	540
2018 Q4	$4K	Hold	234	–	–	﹤0.01%	547
2018 Q3	$5K	Hold	234	–	–	﹤0.01%	586
2018 Q2	$6K	Hold	234	–	–	﹤0.01%	569
2018 Q1	$4K	Hold	234	–	–	﹤0.01%	695
2017 Q4	$4K	Hold	234	–	–	﹤0.01%	663
2017 Q3	$4K	Hold	234	–	–	﹤0.01%	641
2017 Q2	$8K	Hold	234	–	–	﹤0.01%	552
2017 Q1	$8K	Hold	234	–	–	﹤0.01%	592
2016 Q4	$8K	Sell	234 -1,998	-90%	-$79.8K	﹤0.01%	585
2016 Q3	$103K	Buy	2,232 +58	+3%	+$3.03K	0.02%	268
2016 Q2	$109K	Sell	2,174 -200	-8%	-$10.6K	0.03%	246
2016 Q1	$127K	Sell	2,374 -150	-6%	-$8.8K	0.03%	234
2015 Q4	$166K	Buy	2,524 +150	+6%	+$9.27K	0.04%	214
2015 Q3	$134K	Buy	2,374 +2,140	+915%	+$139K	0.04%	245
2015 Q2	$14K	Hold	234	–	–	﹤0.01%	624
2015 Q1	$15K	Sell	234 -370	-61%	-$21.5K	﹤0.01%	627
2014 Q4	$35K	Buy	604 +266	+79%	+$14.8K	0.01%	527
2014 Q3	$18K	Hold	338	–	–	0.01%	617
2014 Q2	$18K	Sell	338 -111	-25%	-$5.67K	﹤0.01%	632
2014 Q1	$24K	Buy	+449	New	+$20.8K	0.01%	590

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Washington Trust Bank's TEVA Position: Q2 2019 in Review

Washington Trust Bank sold out of Teva Pharmaceuticals (TEVA) in Q2 2019, closing a stake of 234 shares — an estimated $4K sold.

Washington Trust Bank first reported a position in TEVA in Q1 2014 and held it in 21 quarters. The position peaked at $166K in Q4 2015. 452 funds tracked by Wall St. Rank hold TEVA as of Q2 2019.

Washington Trust Bank reported no remaining Teva Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Washington Trust Bank sold 234 Teva Pharmaceuticals shares in Q2 2019, an estimated $4K.
Washington Trust Bank first reported a position in Teva Pharmaceuticals in Q1 2014 and held it in 21 quarters.
Washington Trust Bank's Teva Pharmaceuticals position peaked at $166K in Q4 2015.
452 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2019.

Based on Washington Trust Bank's 13F filing for Q2 2019, filed 26 Jul 2019.